XENO

Xeno Transplants Corporation XENO

XENO
Xeno Transplants Corporation TNGNQ
Tengion, Inc. KLDO
Kaleido Biosciences, Inc. BXRXQ
Baudax Bio, Inc. IVBT
Innovation1 Biotech Inc. FPMI
FluoroPharma Medical, Inc. CALA
Calithera Biosciences, Inc. TLOG
TetraLogic Pharmaceuticals Corporation NMRD
Nemaura Medical Inc. CYPS
Cyclo3pss Corporation

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XENO TNGNQ KLDO BXRXQ IVBT FPMI CALA TLOG NMRD CYPS
6M 0.00 % 900.00 % 0.00 % 0.00 % 0.00 % 100.00 % 400.00 % 0.00 % 0.00 % -50.00 %
YTD 0.00 % 900.00 % 0.00 % 900.00 % -80.00 % 100.00 % 66.67 % 0.00 % 0.00 % -50.00 %
1Y 0.00 % 900.00 % 0.00 % 900.00 % -80.00 % 100.00 % 400.00 % 0.00 % -50.00 % -50.00 %
3Y -50.00 % 9 900.00 % -90.91 % -99.96 % -99.79 % -86.67 % -99.98 % 0.00 % -99.99 % -98.00 %
5Y -93.59 % 9 900.00 % -100.00 % -99.96 % -98.33 % -90.91 % -100.00 % -99.31 % -100.00 % -99.68 %
10Y -97.14 % 9 900.00 % -100.00 % -99.96 % -99.98 % -99.93 % -100.00 % -99.99 % -100.00 % -98.00 %
From the beginning -99.90 % 9 900.00 % -100.00 % -99.96 % -99.98 % -99.98 % -100.00 % -100.00 % -100.00 % -99.09 %

Dividend